Indian Journal of Ophthalmology (Jan 2012)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta

  • Pukhraj Rishi,
  • Ekta Rishi,
  • Anusha Venkatraman

DOI
https://doi.org/10.4103/0301-4738.95882
Journal volume & issue
Vol. 60, no. 3
pp. 229 – 231

Abstract

Read online

A 12-year-old girl, diagnosed of osteogenesis imperfecta, presented with sudden visual loss in the left eye. Investigations revealed an active choroidal neovascular membrane. She underwent treatment with intravitreal Bevacizumab (1.25 mg/0.05 ml). Follow-up at 1 month revealed the development of lacquer crack running through the macula, underlying the fovea. The patient received two re-treatments at 1-month intervals, following which the choroidal neovascularization (CNV) regressed completely. However, further progression of lacquer cracks was noted. At the last follow-up, 6 months following the last injection, the fundus remained stable and vision was maintained at 20/200. Considering the natural history of the disease and the increased risk of rupture of the Bruch′s membrane in such eyes, the possible complication of a lacquer crack developing must be borne in mind, before initiating treatment.

Keywords